Lyme Disease Diagnostic Devices Market
PUBLISHED: 2021 ID: SMRC20699
SHARE
SHARE

Lyme Disease Diagnostic Devices Market

Lyme Disease Diagnostic Devices Market Forecasts to 2028 – Global Analysis By Diagnostic Test, Diagnostic Technology Type, End User (Clinical Research Institute, Hospitals, Pharmaceutical Industries, and others) and By Geography

4.2 (59 reviews)
4.2 (59 reviews)
Published: 2021 ID: SMRC20699

This report covers the impact of COVID-19 on this global market
Loading...

According to Stratistics MRC, the Global Lyme Disease Diagnostic Devices Market is accounted for $840.29 million in 2020 and is expected to reach $1,613.86 million by 2028 growing at a CAGR of 8.5% during the forecast period. Upsurge in incidence of Lyme disease, growing policy attention on improving health care services, and the advent of new diagnostic tests for Lyme disease are driving the market growth. However, lack of knowledge of the disease and ineffectiveness in Lyme disease research are hampering the growth of the market.

Lyme disease is a vector-borne illness which is spread by infected ticks. It is not easy to diagnose for many reasons, such as inflammation, dizziness, fatigue, joint or body pains, headaches that are quite common with other diseases, including circular red rash termed as erythema migrants (EM), which doesn’t appear commonly. Hence, it is important to have the advanced diagnostic tool to discover potential targets of Lyme disease instantaneously. There is a substantial need to design rapid, point-of-care tests to determine whether patients are infected with ‘Borrelia burgdorferi’, the bacterium that causes Lyme disease, as early active assessment is imperative to detect to make prompt treatment.

Based on the end user, the hospitals segment is going to have lucrative growth during the forecast period. Hospitals are well-equipped to handle patient flow and employ latest diagnostic and treatment techniques. These factors are primarily responsible for the greater market share of hospitals. By geography, North America is going to have high growth during the forecast period owing to high incidence of Lyme disease and existence of state-of-the-art healthcare infrastructure.

Some of the key players profiled in the Lyme Disease Diagnostic Devices Market include Abbott Laboratories, Affymetrix Inc., Alere Inc (ALR), Baxter International Inc., Bio-Rad Laboratories, Boulder Diagnostics, Canon U.S. Life Sciences, Covance Inc., Fresenius Medical Care AG and Co., GlaxoSmithKline Pharmaceuticals Ltd., Graphene Frontiers, Immunetics Inc., Roche Diagnostics International Ltd., Siemens AG and T2 Biosystems.

Report Coverage

Details

Published Year:

2021

Estimated Market Size in 2020:

USD 840.29 million

Estimated Period:

2020

Compound Annual Growth Rate (CAGR) from 2020 to 2028:

8.5%

Predicted 2028 Value:

USD 1,613.86 million

Forecast Years:

2021-2028

Tables, Graphs& Figures

180

Chapters Covered:

Diagnostic Test, Diagnostic Technologies Type, End User and Region

Core Drivers and Opportunities:

  • Upsurge in incidence of Lyme disease
  • Growing policy attention on improving health care services
  • Advent of new diagnostic tests for Lyme disease

Restraining Factors & Market Threats:

  • Lack of knowledge of the disease
  • Ineffectiveness in Lyme disease research


Diagnostic Tests Covered:
• Serological Test
• Dark Field Microscopy
• Immunofluorescent Staining
• Lymphocytic Transformation Test
• Nucleic Acid Amplification
• Polymerase Chain Reaction (PCR) Analysis
• Urine Antigen Tests

Diagnostic Technologies Types Covered:
• Brain Magnetic Resonance Imaging (MRI)
• Echocardiogram
• Electrocardiogram
• Flow Cytometry
• Gel Microdroplets
• Molecular Diagnostics
• Monoclonal Antibodies
• Spinal Tap  

End Users Covered:
• Clinical Research Institute
• Hospitals
• Pathology Labs
• Pharmaceutical Industries
• Physician’s Office
• Public/Private Laboratories   

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan       
o China       
o India       
o Australia 
o New Zealand
o South Korea
o Rest of Asia Pacific   
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2019, 2020, 2021, 2025 and 2028
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Key Questions Answered In The Report

The Global Lyme Disease Diagnostic Devices Market is majorly driven by upsurge in incidence of Lyme disease, growing policy attention on improving health care services, and the advent of new diagnostic tests for Lyme disease.

The brain magnetic resonance imaging (MRI) segment is growing at a highest CAGR owing to the diagnosis of Lyme Neuroborreliosis (LNB) in brainstem and medulla owing to numerous case reports elaborate that LNB has a huge spectrum of imaging entities in patients.

North America dominated with a significant market share due to the factors such as mounting Lyme disease cases, which also has a constellation of symptoms, have been challenging to diagnose.

Europe market is growing at a highest CAGR owing to rising Lyme disease cases, and a great need to design rapid point-of-care technologies to determine the Lyme infection.

Key players in Lyme Disease Diagnostic Devices Market include Abbott Laboratories, Affymetrix Inc., Alere Inc (ALR), Baxter International Inc., Bio-Rad Laboratories, Boulder Diagnostics, Canon U.S. Life Sciences, Covance Inc., Fresenius Medical Care AG and Co., GlaxoSmithKline Pharmaceuticals Ltd., Graphene Frontiers, Immunetics Inc., Roche Diagnostics International Ltd., Siemens AG and T2 Biosystems.

Table of Contents

1 Executive Summary    
     
2 Preface    

 2.1 Abstract   
 2.2 Stake Holders   
 2.3 Research Scope   
 2.4 Research Methodology   
  2.4.1 Data Mining  
  2.4.2 Data Analysis  
  2.4.3 Data Validation  
  2.4.4 Research Approach  
 2.5 Research Sources   
  2.5.1 Primary Research Sources  
  2.5.2 Secondary Research Sources  
  2.5.3 Assumptions  
     
3 Market Trend Analysis    
 3.1 Introduction   
 3.2 Drivers   
 3.3 Restraints   
 3.4 Opportunities   
 3.5 Threats   
 3.6 Technology Analysis   
 3.7 End User Analysis   
 3.8 Emerging Markets   
 3.9 Impact of Covid-19   
     
4 Porters Five Force Analysis    
 4.1 Bargaining power of suppliers   
 4.2 Bargaining power of buyers   
 4.3 Threat of substitutes   
 4.4 Threat of new entrants   
 4.5 Competitive rivalry   
     
5 Global Lyme Disease Diagnostic Devices Market, By Diagnostic Test    
 5.1 Introduction   
 5.2 Serological Test   
  5.2.1 Enzyme-Linked Fluorescent Immunoassay (ELFA)  
  5.2.2 Enzyme-Linked Immunosorbent Assay (ELISA)  
  5.2.3 Western Blot  
 5.3 Dark Field Microscopy   
 5.4 Immunofluorescent Staining   
 5.5 Lymphocytic Transformation Test   
 5.6 Nucleic Acid Amplification    
 5.7 Polymerase Chain Reaction (PCR) Analysis   
 5.8 Urine Antigen Tests   
     
6 Global Lyme Disease Diagnostic Devices Market, By Diagnostic Technologies Type    
 6.1 Introduction   
 6.2 Brain Magnetic Resonance Imaging (MRI)    
 6.3 Echocardiogram    
 6.4 Electrocardiogram    
 6.5 Flow Cytometry    
 6.6 Gel Microdroplets   
 6.7 Molecular Diagnostics    
 6.8 Monoclonal Antibodies    
 6.9 Spinal Tap    
     
7 Global Lyme Disease Diagnostic Devices Market, By End User    
 7.1 Introduction    
 7.2 Clinical Research Institute   
 7.3 Hospitals   
 7.4 Pathology Labs    
 7.5 Pharmaceutical Industries    
 7.6 Physician's Office   
 7.7 Public/Private Laboratories   
     
8 Global Lyme Disease Diagnostic Devices Market, By Geography     
 8.1 Introduction   
 8.2 North America   
  8.2.1 US  
  8.2.2 Canada  
  8.2.3 Mexico  
 8.3 Europe   
  8.3.1 Germany  
  8.3.2 UK  
  8.3.3 Italy  
  8.3.4 France  
  8.3.5 Spain  
  8.3.6 Rest of Europe  
 8.4 Asia Pacific   
  8.4.1 Japan  
  8.4.2 China  
  8.4.3 India  
  8.4.4 Australia  
  8.4.5 New Zealand  
  8.4.6 South Korea  
  8.4.7 Rest of Asia Pacific  
 8.5 South America   
  8.5.1 Argentina  
  8.5.2 Brazil  
  8.5.3 Chile  
  8.5.4 Rest of South America  
 8.6 Middle East & Africa   
  8.6.1 Saudi Arabia  
  8.6.2 UAE  
  8.6.3 Qatar  
  8.6.4 South Africa  
  8.6.5 Rest of Middle East & Africa  
     
9 Key Developments    

 9.1 Agreements, Partnerships, Collaborations and Joint Ventures   
 9.2 Acquisitions & Mergers   
 9.3 New Product Launch   
 9.4 Expansions   
 9.5 Other Key Strategies   
     
10 Company Profiling    
 10.1 Abbott Laboratories   
 10.2 Affymetrix Inc.   
 10.3 Alere Inc (ALR)   
 10.4 Baxter International Inc.   
 10.5 Bio-Rad Laboratories   
 10.6 Boulder Diagnostics   
 10.7 Canon U.S. Life Sciences   
 10.8 Covance Inc.   
 10.9 Fresenius Medical Care AG and Co.   
 10.10 GlaxoSmithKline Pharmaceuticals Ltd.   
 10.11 Graphene Frontiers   
 10.12 Immunetics Inc.   
 10.13 Roche Diagnostics International Ltd.   
 10.14 Siemens AG   
 10.15 T2 Biosystems   


List of Tables     
1 Global Lyme Disease Diagnostic Devices Market Outlook, By Region (2019-2028) (US $MN)     
2 Global Lyme Disease Diagnostic Devices Market Outlook, By Diagnostic Test (2019-2028) (US $MN)     
3 Global Lyme Disease Diagnostic Devices Market Outlook, By Serological Test (2019-2028) (US $MN)     
4 Global Lyme Disease Diagnostic Devices Market Outlook, By Enzyme-Linked Fluorescent Immunoassay (ELFA) (2019-2028) (US $MN)     
5 Global Lyme Disease Diagnostic Devices Market Outlook, By Enzyme-Linked Immunosorbent Assay (ELISA) (2019-2028) (US $MN)     
6 Global Lyme Disease Diagnostic Devices Market Outlook, By Western Blot (2019-2028) (US $MN)     
7 Global Lyme Disease Diagnostic Devices Market Outlook, By Dark Field Microscopy (2019-2028) (US $MN)     
8 Global Lyme Disease Diagnostic Devices Market Outlook, By Immunofluorescent Staining (2019-2028) (US $MN)     
9 Global Lyme Disease Diagnostic Devices Market Outlook, By Lymphocytic Transformation Test (2019-2028) (US $MN)     
10 Global Lyme Disease Diagnostic Devices Market Outlook, By Nucleic Acid Amplification  (2019-2028) (US $MN)     
11 Global Lyme Disease Diagnostic Devices Market Outlook, By Polymerase Chain Reaction (PCR) Analysis (2019-2028) (US $MN)     
12 Global Lyme Disease Diagnostic Devices Market Outlook, By Urine Antigen Tests (2019-2028) (US $MN)     
13 Global Lyme Disease Diagnostic Devices Market Outlook, By Diagnostic Technologies Type (2019-2028) (US $MN)     
14 Global Lyme Disease Diagnostic Devices Market Outlook, By Brain Magnetic Resonance Imaging (MRI)  (2019-2028) (US $MN)     
15 Global Lyme Disease Diagnostic Devices Market Outlook, By Echocardiogram  (2019-2028) (US $MN)     
16 Global Lyme Disease Diagnostic Devices Market Outlook, By Electrocardiogram  (2019-2028) (US $MN)     
17 Global Lyme Disease Diagnostic Devices Market Outlook, By Flow Cytometry  (2019-2028) (US $MN)     
18 Global Lyme Disease Diagnostic Devices Market Outlook, By Gel Microdroplets (2019-2028) (US $MN)     
19 Global Lyme Disease Diagnostic Devices Market Outlook, By Molecular Diagnostics  (2019-2028) (US $MN)     
20 Global Lyme Disease Diagnostic Devices Market Outlook, By Monoclonal Antibodies  (2019-2028) (US $MN)     
21 Global Lyme Disease Diagnostic Devices Market Outlook, By Spinal Tap  (2019-2028) (US $MN)     
22 Global Lyme Disease Diagnostic Devices Market Outlook, By End User (2019-2028) (US $MN)     
23 Global Lyme Disease Diagnostic Devices Market Outlook, By Clinical Research Institute (2019-2028) (US $MN)     
24 Global Lyme Disease Diagnostic Devices Market Outlook, By Hospitals (2019-2028) (US $MN)     
25 Global Lyme Disease Diagnostic Devices Market Outlook, By Pathology Labs  (2019-2028) (US $MN)     
26 Global Lyme Disease Diagnostic Devices Market Outlook, By Pharmaceutical Industries  (2019-2028) (US $MN)     
27 Global Lyme Disease Diagnostic Devices Market Outlook, By Physician's Office (2019-2028) (US $MN)     
28 Global Lyme Disease Diagnostic Devices Market Outlook, By Public/Private Laboratories (2019-2028) (US $MN)     
29 North America Lyme Disease Diagnostic Devices Market Outlook, By Country (2019-2028) (US $MN)      
30 North America Lyme Disease Diagnostic Devices Market Outlook, By Diagnostic Test (2019-2028) (US $MN)     
31 North America Lyme Disease Diagnostic Devices Market Outlook, By Serological Test (2019-2028) (US $MN)     
32 North America Lyme Disease Diagnostic Devices Market Outlook, By Enzyme-Linked Fluorescent Immunoassay (ELFA) (2019-2028) (US $MN)     
33 North America Lyme Disease Diagnostic Devices Market Outlook, By Enzyme-Linked Immunosorbent Assay (ELISA) (2019-2028) (US $MN)     
34 North America Lyme Disease Diagnostic Devices Market Outlook, By Western Blot (2019-2028) (US $MN)     
35 North America Lyme Disease Diagnostic Devices Market Outlook, By Dark Field Microscopy (2019-2028) (US $MN)     
36 North America Lyme Disease Diagnostic Devices Market Outlook, By Immunofluorescent Staining (2019-2028) (US $MN)     
37 North America Lyme Disease Diagnostic Devices Market Outlook, By Lymphocytic Transformation Test (2019-2028) (US $MN)     
38 North America Lyme Disease Diagnostic Devices Market Outlook, By Nucleic Acid Amplification  (2019-2028) (US $MN)     
39 North America Lyme Disease Diagnostic Devices Market Outlook, By Polymerase Chain Reaction (PCR) Analysis (2019-2028) (US $MN)     
40 North America Lyme Disease Diagnostic Devices Market Outlook, By Urine Antigen Tests (2019-2028) (US $MN)     
41 North America Lyme Disease Diagnostic Devices Market Outlook, By Diagnostic Technologies Type (2019-2028) (US $MN)     
42 North America Lyme Disease Diagnostic Devices Market Outlook, By Brain Magnetic Resonance Imaging (MRI)  (2019-2028) (US $MN)     
43 North America Lyme Disease Diagnostic Devices Market Outlook, By Echocardiogram  (2019-2028) (US $MN)     
44 North America Lyme Disease Diagnostic Devices Market Outlook, By Electrocardiogram  (2019-2028) (US $MN)     
45 North America Lyme Disease Diagnostic Devices Market Outlook, By Flow Cytometry  (2019-2028) (US $MN)     
46 North America Lyme Disease Diagnostic Devices Market Outlook, By Gel Microdroplets (2019-2028) (US $MN)     
47 North America Lyme Disease Diagnostic Devices Market Outlook, By Molecular Diagnostics  (2019-2028) (US $MN)     
48 North America Lyme Disease Diagnostic Devices Market Outlook, By Monoclonal Antibodies  (2019-2028) (US $MN)     
49 North America Lyme Disease Diagnostic Devices Market Outlook, By Spinal Tap  (2019-2028) (US $MN)     
50 North America Lyme Disease Diagnostic Devices Market Outlook, By End User (2019-2028) (US $MN)     
51 North America Lyme Disease Diagnostic Devices Market Outlook, By Clinical Research Institute (2019-2028) (US $MN)     
52 North America Lyme Disease Diagnostic Devices Market Outlook, By Hospitals (2019-2028) (US $MN)     
53 North America Lyme Disease Diagnostic Devices Market Outlook, By Pathology Labs  (2019-2028) (US $MN)     
54 North America Lyme Disease Diagnostic Devices Market Outlook, By Pharmaceutical Industries  (2019-2028) (US $MN)     
55 North America Lyme Disease Diagnostic Devices Market Outlook, By Physician's Office (2019-2028) (US $MN)     
56 North America Lyme Disease Diagnostic Devices Market Outlook, By Public/Private Laboratories (2019-2028) (US $MN)     
57 Europe Lyme Disease Diagnostic Devices Market Outlook, By Country (2019-2028) (US $MN)     
58 Europe Lyme Disease Diagnostic Devices Market Outlook, By Diagnostic Test (2019-2028) (US $MN)     
59 Europe Lyme Disease Diagnostic Devices Market Outlook, By Serological Test (2019-2028) (US $MN)     
60 Europe Lyme Disease Diagnostic Devices Market Outlook, By Enzyme-Linked Fluorescent Immunoassay (ELFA) (2019-2028) (US $MN)     
61 Europe Lyme Disease Diagnostic Devices Market Outlook, By Enzyme-Linked Immunosorbent Assay (ELISA) (2019-2028) (US $MN)     
62 Europe Lyme Disease Diagnostic Devices Market Outlook, By Western Blot (2019-2028) (US $MN)     
63 Europe Lyme Disease Diagnostic Devices Market Outlook, By Dark Field Microscopy (2019-2028) (US $MN)     
64 Europe Lyme Disease Diagnostic Devices Market Outlook, By Immunofluorescent Staining (2019-2028) (US $MN)      
65 Europe Lyme Disease Diagnostic Devices Market Outlook, By Lymphocytic Transformation Test (2019-2028) (US $MN)     
66 Europe Lyme Disease Diagnostic Devices Market Outlook, By Nucleic Acid Amplification  (2019-2028) (US $MN)     
67 Europe Lyme Disease Diagnostic Devices Market Outlook, By Polymerase Chain Reaction (PCR) Analysis (2019-2028) (US $MN)     
68 Europe Lyme Disease Diagnostic Devices Market Outlook, By Urine Antigen Tests (2019-2028) (US $MN)     
69 Europe Lyme Disease Diagnostic Devices Market Outlook, By Diagnostic Technologies Type (2019-2028) (US $MN)     
70 Europe Lyme Disease Diagnostic Devices Market Outlook, By Brain Magnetic Resonance Imaging (MRI)  (2019-2028) (US $MN)     
71 Europe Lyme Disease Diagnostic Devices Market Outlook, By Echocardiogram  (2019-2028) (US $MN)     
72 Europe Lyme Disease Diagnostic Devices Market Outlook, By Electrocardiogram  (2019-2028) (US $MN)     
73 Europe Lyme Disease Diagnostic Devices Market Outlook, By Flow Cytometry  (2019-2028) (US $MN)     
74 Europe Lyme Disease Diagnostic Devices Market Outlook, By Gel Microdroplets (2019-2028) (US $MN)     
75 Europe Lyme Disease Diagnostic Devices Market Outlook, By Molecular Diagnostics  (2019-2028) (US $MN)     
76 Europe Lyme Disease Diagnostic Devices Market Outlook, By Monoclonal Antibodies  (2019-2028) (US $MN)     
77 Europe Lyme Disease Diagnostic Devices Market Outlook, By Spinal Tap  (2019-2028) (US $MN)     
78 Europe Lyme Disease Diagnostic Devices Market Outlook, By End User (2019-2028) (US $MN)     
79 Europe Lyme Disease Diagnostic Devices Market Outlook, By Clinical Research Institute (2019-2028) (US $MN)     
80 Europe Lyme Disease Diagnostic Devices Market Outlook, By Hospitals (2019-2028) (US $MN)     
81 Europe Lyme Disease Diagnostic Devices Market Outlook, By Pathology Labs  (2019-2028) (US $MN)     
82 Europe Lyme Disease Diagnostic Devices Market Outlook, By Pharmaceutical Industries  (2019-2028) (US $MN)     
83 Europe Lyme Disease Diagnostic Devices Market Outlook, By Physician's Office (2019-2028) (US $MN)     
84 Europe Lyme Disease Diagnostic Devices Market Outlook, By Public/Private Laboratories (2019-2028) (US $MN)     
85 Asia Pacific Lyme Disease Diagnostic Devices Market Outlook, By Country (2019-2028) (US $MN)     
86 Asia Pacific Lyme Disease Diagnostic Devices Market Outlook, By Diagnostic Test (2019-2028) (US $MN)     
87 Asia Pacific Lyme Disease Diagnostic Devices Market Outlook, By Serological Test (2019-2028) (US $MN)     
88 Asia Pacific Lyme Disease Diagnostic Devices Market Outlook, By Enzyme-Linked Fluorescent Immunoassay (ELFA) (2019-2028) (US $MN)     
89 Asia Pacific Lyme Disease Diagnostic Devices Market Outlook, By Enzyme-Linked Immunosorbent Assay (ELISA) (2019-2028) (US $MN)     
90 Asia Pacific Lyme Disease Diagnostic Devices Market Outlook, By Western Blot (2019-2028) (US $MN)     
91 Asia Pacific Lyme Disease Diagnostic Devices Market Outlook, By Dark Field Microscopy (2019-2028) (US $MN)     
92 Asia Pacific Lyme Disease Diagnostic Devices Market Outlook, By Immunofluorescent Staining (2019-2028) (US $MN)     
93 Asia Pacific Lyme Disease Diagnostic Devices Market Outlook, By Lymphocytic Transformation Test (2019-2028) (US $MN)     
94 Asia Pacific Lyme Disease Diagnostic Devices Market Outlook, By Nucleic Acid Amplification  (2019-2028) (US $MN)     
95 Asia Pacific Lyme Disease Diagnostic Devices Market Outlook, By Polymerase Chain Reaction (PCR) Analysis (2019-2028) (US $MN)     
96 Asia Pacific Lyme Disease Diagnostic Devices Market Outlook, By Urine Antigen Tests (2019-2028) (US $MN)     
97 Asia Pacific Lyme Disease Diagnostic Devices Market Outlook, By Diagnostic Technologies Type (2019-2028) (US $MN)     
98 Asia Pacific Lyme Disease Diagnostic Devices Market Outlook, By Brain Magnetic Resonance Imaging (MRI)  (2019-2028) (US $MN)     
99 Asia Pacific Lyme Disease Diagnostic Devices Market Outlook, By Echocardiogram  (2019-2028) (US $MN)     
100 Asia Pacific Lyme Disease Diagnostic Devices Market Outlook, By Electrocardiogram  (2019-2028) (US $MN)     
101 Asia Pacific Lyme Disease Diagnostic Devices Market Outlook, By Flow Cytometry  (2019-2028) (US $MN)     
102 Asia Pacific Lyme Disease Diagnostic Devices Market Outlook, By Gel Microdroplets (2019-2028) (US $MN)     
103 Asia Pacific Lyme Disease Diagnostic Devices Market Outlook, By Molecular Diagnostics  (2019-2028) (US $MN)     
104 Asia Pacific Lyme Disease Diagnostic Devices Market Outlook, By Monoclonal Antibodies  (2019-2028) (US $MN)     
105 Asia Pacific Lyme Disease Diagnostic Devices Market Outlook, By Spinal Tap  (2019-2028) (US $MN)     
106 Asia Pacific Lyme Disease Diagnostic Devices Market Outlook, By End User (2019-2028) (US $MN)     
107 Asia Pacific Lyme Disease Diagnostic Devices Market Outlook, By Clinical Research Institute (2019-2028) (US $MN)     
108 Asia Pacific Lyme Disease Diagnostic Devices Market Outlook, By Hospitals (2019-2028) (US $MN)     
109 Asia Pacific Lyme Disease Diagnostic Devices Market Outlook, By Pathology Labs  (2019-2028) (US $MN)     
110 Asia Pacific Lyme Disease Diagnostic Devices Market Outlook, By Pharmaceutical Industries  (2019-2028) (US $MN)     
111 Asia Pacific Lyme Disease Diagnostic Devices Market Outlook, By Physician's Office (2019-2028) (US $MN)      
112 Asia Pacific Lyme Disease Diagnostic Devices Market Outlook, By Public/Private Laboratories (2019-2028) (US $MN)     
113 South America Lyme Disease Diagnostic Devices Market Outlook, By Country (2019-2028) (US $MN)     
114 South America Lyme Disease Diagnostic Devices Market Outlook, By Diagnostic Test (2019-2028) (US $MN)     
115 South America Lyme Disease Diagnostic Devices Market Outlook, By Serological Test (2019-2028) (US $MN)     
116 South America Lyme Disease Diagnostic Devices Market Outlook, By Enzyme-Linked Fluorescent Immunoassay (ELFA) (2019-2028) (US $MN)     
117 South America Lyme Disease Diagnostic Devices Market Outlook, By Enzyme-Linked Immunosorbent Assay (ELISA) (2019-2028) (US $MN)     
118 South America Lyme Disease Diagnostic Devices Market Outlook, By Western Blot (2019-2028) (US $MN)     
119 South America Lyme Disease Diagnostic Devices Market Outlook, By Dark Field Microscopy (2019-2028) (US $MN)     
120 South America Lyme Disease Diagnostic Devices Market Outlook, By Immunofluorescent Staining (2019-2028) (US $MN)     
121 South America Lyme Disease Diagnostic Devices Market Outlook, By Lymphocytic Transformation Test (2019-2028) (US $MN)     
122 South America Lyme Disease Diagnostic Devices Market Outlook, By Nucleic Acid Amplification  (2019-2028) (US $MN)     
123 South America Lyme Disease Diagnostic Devices Market Outlook, By Polymerase Chain Reaction (PCR) Analysis (2019-2028) (US $MN)     
124 South America Lyme Disease Diagnostic Devices Market Outlook, By Urine Antigen Tests (2019-2028) (US $MN)     
125 South America Lyme Disease Diagnostic Devices Market Outlook, By Diagnostic Technologies Type (2019-2028) (US $MN)     
126 South America Lyme Disease Diagnostic Devices Market Outlook, By Brain Magnetic Resonance Imaging (MRI)  (2019-2028) (US $MN)     
127 South America Lyme Disease Diagnostic Devices Market Outlook, By Echocardiogram  (2019-2028) (US $MN)     
128 South America Lyme Disease Diagnostic Devices Market Outlook, By Electrocardiogram  (2019-2028) (US $MN)     
129 South America Lyme Disease Diagnostic Devices Market Outlook, By Flow Cytometry  (2019-2028) (US $MN)     
130 South America Lyme Disease Diagnostic Devices Market Outlook, By Gel Microdroplets (2019-2028) (US $MN)      
131 South America Lyme Disease Diagnostic Devices Market Outlook, By Molecular Diagnostics  (2019-2028) (US $MN)     
132 South America Lyme Disease Diagnostic Devices Market Outlook, By Monoclonal Antibodies  (2019-2028) (US $MN)     
133 South America Lyme Disease Diagnostic Devices Market Outlook, By Spinal Tap  (2019-2028) (US $MN)     
134 South America Lyme Disease Diagnostic Devices Market Outlook, By End User (2019-2028) (US $MN)     
135 South America Lyme Disease Diagnostic Devices Market Outlook, By Clinical Research Institute (2019-2028) (US $MN)     
136 South America Lyme Disease Diagnostic Devices Market Outlook, By Hospitals (2019-2028) (US $MN)     
137 South America Lyme Disease Diagnostic Devices Market Outlook, By Pathology Labs  (2019-2028) (US $MN)     
138 South America Lyme Disease Diagnostic Devices Market Outlook, By Pharmaceutical Industries  (2019-2028) (US $MN)     
139 South America Lyme Disease Diagnostic Devices Market Outlook, By Physician's Office (2019-2028) (US $MN)     
140 South America Lyme Disease Diagnostic Devices Market Outlook, By Public/Private Laboratories (2019-2028) (US $MN)     
141 Middle East & Africa Lyme Disease Diagnostic Devices Market Outlook, By Country (2019-2028) (US $MN)     
142 Middle East & Africa Lyme Disease Diagnostic Devices Market Outlook, By Diagnostic Test (2019-2028) (US $MN)     
143 Middle East & Africa Lyme Disease Diagnostic Devices Market Outlook, By Serological Test (2019-2028) (US $MN)     
144 Middle East & Africa Lyme Disease Diagnostic Devices Market Outlook, By Enzyme-Linked Fluorescent Immunoassay (ELFA) (2019-2028) (US $MN)     
145 Middle East & Africa Lyme Disease Diagnostic Devices Market Outlook, By Enzyme-Linked Immunosorbent Assay (ELISA) (2019-2028) (US $MN)     
146 Middle East & Africa Lyme Disease Diagnostic Devices Market Outlook, By Western Blot (2019-2028) (US $MN)     
147 Middle East & Africa Lyme Disease Diagnostic Devices Market Outlook, By Dark Field Microscopy (2019-2028) (US $MN)     
148 Middle East & Africa Lyme Disease Diagnostic Devices Market Outlook, By Immunofluorescent Staining (2019-2028) (US $MN)     
149 Middle East & Africa Lyme Disease Diagnostic Devices Market Outlook, By Lymphocytic Transformation Test (2019-2028) (US $MN)      
150 Middle East & Africa Lyme Disease Diagnostic Devices Market Outlook, By Nucleic Acid Amplification  (2019-2028) (US $MN)     
151 Middle East & Africa Lyme Disease Diagnostic Devices Market Outlook, By Polymerase Chain Reaction (PCR) Analysis (2019-2028) (US $MN)     
152 Middle East & Africa Lyme Disease Diagnostic Devices Market Outlook, By Urine Antigen Tests (2019-2028) (US $MN)     
153 Middle East & Africa Lyme Disease Diagnostic Devices Market Outlook, By Diagnostic Technologies Type (2019-2028) (US $MN)     
154 Middle East & Africa Lyme Disease Diagnostic Devices Market Outlook, By Brain Magnetic Resonance Imaging (MRI)  (2019-2028) (US $MN)     
155 Middle East & Africa Lyme Disease Diagnostic Devices Market Outlook, By Echocardiogram  (2019-2028) (US $MN)     
156 Middle East & Africa Lyme Disease Diagnostic Devices Market Outlook, By Electrocardiogram  (2019-2028) (US $MN)     
157 Middle East & Africa Lyme Disease Diagnostic Devices Market Outlook, By Flow Cytometry  (2019-2028) (US $MN)     
158 Middle East & Africa Lyme Disease Diagnostic Devices Market Outlook, By Gel Microdroplets (2019-2028) (US $MN)     
159 Middle East & Africa Lyme Disease Diagnostic Devices Market Outlook, By Molecular Diagnostics  (2019-2028) (US $MN)      
160 Middle East & Africa Lyme Disease Diagnostic Devices Market Outlook, By Monoclonal Antibodies  (2019-2028) (US $MN)     
161 Middle East & Africa Lyme Disease Diagnostic Devices Market Outlook, By Spinal Tap  (2019-2028) (US $MN)     
162 Middle East & Africa Lyme Disease Diagnostic Devices Market Outlook, By End User (2019-2028) (US $MN)     
163 Middle East & Africa Lyme Disease Diagnostic Devices Market Outlook, By Clinical Research Institute (2019-2028) (US $MN)     
164 Middle East & Africa Lyme Disease Diagnostic Devices Market Outlook, By Hospitals (2019-2028) (US $MN)     
165 Middle East & Africa Lyme Disease Diagnostic Devices Market Outlook, By Pathology Labs  (2019-2028) (US $MN)     
166 Middle East & Africa Lyme Disease Diagnostic Devices Market Outlook, By Pharmaceutical Industries  (2019-2028) (US $MN)     
167 Middle East & Africa Lyme Disease Diagnostic Devices Market Outlook, By Physician's Office (2019-2028) (US $MN)     
168 Middle East & Africa Lyme Disease Diagnostic Devices Market Outlook, By Public/Private Laboratories (2019-2028) (US $MN) 

List of Figures

RESEARCH METHODOLOGY


Research Methodology

We at Stratistics opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.

Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.

Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.

Data Mining

The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.

Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.

Data Analysis

From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:

  • Product Lifecycle Analysis
  • Competitor analysis
  • Risk analysis
  • Porters Analysis
  • PESTEL Analysis
  • SWOT Analysis

The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.


Data Validation

The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.

We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.

The data validation involves the primary research from the industry experts belonging to:

  • Leading Companies
  • Suppliers & Distributors
  • Manufacturers
  • Consumers
  • Industry/Strategic Consultants

Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.


For more details about research methodology, kindly write to us at info@strategymrc.com

Frequently Asked Questions

In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.

Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.

All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

We have 3 different licensing options available in electronic format.

  • Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
  • 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
  • Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.

All our reports are typically be emailed to you as an attachment.

To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.

We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.

Request Customization

We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.

WHY CHOOSE US ?

Assured Quality

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Free Customization

Adding more values to your product of interest.

Safe and Secure Access

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Trusted by 600+ Brands

Serving the most reputed brands across the world.

Testimonials